MENS

Jyong Biotech Ltd. Ordinary Shares

NASDAQ: MENS · HEALTHCARE · BIOTECHNOLOGY

$2.03

+0.50% today

Updated 2026-08-07

Market cap

$163.46M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.06

Dividend yield

—

52W range

$1 – $67

Volume

0.1M

Market cap

$163.46M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.06

Dividend yield

—

52W range

$1 – $67

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.5

Profitability

5.0

Valuation

C+

5/9

Piotroski F-Score

Moderate

-4.1

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →211 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Debt/equity -0.74x — low leverage

Risks

- Altman Z -4.07 — distress zone

- Thin margins at 0.00%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	—
Net income	$-6.63M	$-4.40M	$-3.02M	$-4.67M	$-3.42M
EPS	—	—	—	—	$-0.06
Free cash flow	$-3.22M	$-2.60M	$-3.62M	$-3.04M	—
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MENS	$163.46M	17	4.3	3.5	5.0	5.0	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$614.36B	57	4.7	8.5	3.3	6.0	-84.82%	Buy
ABBV	$430.82B	73	6.7	8.5	4.7	5.0	-63.15%	Strong Buy
UNH	$370.11B	62	7.3	5.5	4.0	6.0	-28.08%	Buy
MRK	$316.14B	50	3.3	8.0	2.7	5.0	-57.98%	Hold

Smart narrative

Jyong Biotech Ltd. Ordinary Shares trades at $2.03. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -4.07, it sits in the distress.

Frequently asked questions

What is Jyong Biotech Ltd. Ordinary Shares's stock price?

Jyong Biotech Ltd. Ordinary Shares (MENS) trades at $2.03.

Is Jyong Biotech Ltd. Ordinary Shares overvalued?

Jyong Biotech Ltd. Ordinary Shares carries a Smart Value Score of 17/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Jyong Biotech Ltd. Ordinary Shares's Altman Z-Score is -4.07, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

jyongbio.com

Quick metrics

P/S ratio—

ROE—

Beta—

50D MA$2.09

200D MA$10.60

Shares out0.07B

Float0.03B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

MENS vs LLY →MENS vs JNJ →MENS vs ABBV →Stock screener →